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Background/Purpose: Diagnosis and management of the metabolic syndrome (MetS) are beneﬁcial for
successful aging. In spite of several criteria for MetS, there is little information on cardiometabolic risk
clustering in elderly Japanese. The purpose of this study was, therefore, to determine the relationship
between age-associated changes in obesity and metabolic components in the Japanese.
Methods:We analyzed data from the nationwide survey conducted in 2000. Using Adult Treatment Panel
III (ATP III) and Japanese diagnostic criteria for MetS, we analyzed 2366 people aged from 40 to 79 years
(men, 1425 and women, 941) from the total participants.
Results: The prevalence of MetS was almost three fold higher by modiﬁed ATP III, International Diabetes
Federation, and Japanese criteria, in elderly women than in middle-aged women, whereas no difference
was found betweenmiddle-aged and elderlymen by the three criteria. Amarked increase in the prevalence
ofMetSwas found bymodiﬁedATP III and International Diabetes Federation criteria comparedwith that by
the Japanese criteria inwomen. Among the risk factors, the prevalence of central obesity and dyslipidemia
increasedonly inwomenand that of high fasting glucose andhighbloodpressure increased inboth genders
with aging. Among theMetS subjects who fulﬁlled themodiﬁed ATP III criteria, more clustering of risk was
observed in elderly than in middle-aged subjects, especially in women. Blood pressure increased and
triglyceride decreased in both genders, and non-high-density-lipoprotein cholesterol decreased in elderly
men. The prevalence of dyslipidemia decreased in elderly men.
Conclusion: Aging is an important factor that affects the metabolic abnormality, and aging of the pop-
ulation would lead to increase in the prevalence of MetS. Therefore, the development of better
approaches to the prevention and management of MetS is necessary for successful aging in our society.
Copyright  2010, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
 
Open access under CC BY-NC-ND license.LLC.alth Sciences, Kyoto Univer-
o, Shogoin, Sakyo-ku, Kyoto
).
Clinical Gerontology & Geriatrics. P1. Introduction
In the developed countries, life expectancy has shown
a continuous increase in the last decades, especially in Japan, along
with an increase in age-associated diseases and disabilities.ublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
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will endure more chronic medical conditions, such as cardiovas-
cular disease, dyslipidemia, diabetes mellitus, chronic kidney
disease, and the metabolic syndrome (MetS). MetS is a constella-
tion of multiple risk factors, such as central obesity, dyslipidemia,
elevated glucose, and elevated blood pressure, in which insulin
resistance is the main underlying disorder.1 Because the degree of
insulin resistance increases with age, elderly are at a higher risk to
develop cardiometabolic disorders.2 At the same time, elderly with
MetS are supposed to have a higher risk of cardiovascular disease.3
In elderly, the diagnosis of MetS is also related to a more
pronounced cognitive decline and, thus, disability.4 Therefore, the
identiﬁcation and treatment of patients with MetS would be an
important approach to reduce morbidity and impairment in
elderly.
In 2000, we conducted lipid survey in various districts in Japan.5
In this survey, we found that the level of triglyceride increased in
middle-aged men along with the increased body mass index (BMI)
compared with the data in 1990.6 However, the BMI did not change
in the elderly population in spite of a small increase in triglyceride
levels. Although MetS is a risk factor for cardiovascular disease in
middle-aged and elderly people and, therefore, a public health
problem, it is still unknown whether the same diagnostic criteria
can be applied to both groups.
In the last few years, several expert groups have attempted to
set forth simple diagnostic criteria to be used in clinical practice to
identify patients with MetS. The committee of International Dia-
betes Federation (IDF) adopted waist circumference as the surro-
gate marker for central obesity as an essential component of this
syndrome,7 whereas the National Cholesterol Education Program
Adult Treatment Panel III (ATP III) criteria required no single factor
for diagnosis, but instead, required the presence of at least three out
of ﬁve components for the diagnosis.1 In Japan, the committee has
established the diagnostic criteria under the same principle as the
IDF criteria, except the cutoff for high glucose as 110 mg/dL instead
of 100 mg/dL.8 The cutoff of waist circumference for central obesity
was adopted as 85 cm or greater in men and 90 cm or greater in
women in Japanese criteria, although the Asian cutoff of waist
circumference is 90 cm or greater in men and 80 cm or greater in
women. Recently, several groups have shown that the Asian cutoff
for the waist circumference is better than that of the Japanese.9e12
Furthermore, Hata et al.13 have shown that MetS deﬁned by the
Japanese criteria, with the modiﬁcation of a waist circumference of
90 cm or greater in men and 80 cm or greater in women, is a better
predictor of each ischemic stroke subtype in the Japanese pop-
ulation. Therefore, modiﬁcation of the Japanese criteria for MetS
might be necessary in the future.
The purpose of this study was to examine the prevalence of
MetS in the Japanese elderly population and to compare the
prevalence of MetS and comorbidities with those in the middle-
aged population. We also compared the prevalence of MetS by
modiﬁed ATP III, IDF, and Japanese diagnostic criteria.
2. Methods
2.1. Designs and data collection
The Research Group on Serum Lipid Level Survey 2000 in Japan
asked the members of 36 institutes from various areas around
Japan to join this survey. The project was designed to produce
representative data of serum lipid levels in the civilian Japanese
population. The subjects were people receiving annual health
examinations in general community, companies, and schools, and
not those visiting hospitals. Among the total number of 12,839
participants, wemeasured thewaist circumferences of 3264 peopleaged 20e79 years (men, 1917 and women, 1357). In this study, we
examined the prevalence of MetS in subjects aged 40e79 years
(men,1425 andwomen, 941) and compared the prevalence of MetS
along with each metabolic abnormality according to the Japanese
and ATP III criteria. The Ethics Committee in Kyoto University
School of Medicine approved this study. Oral informed consent was
obtained from all the participants.
2.2. Laboratory methods
All serum and plasma samples were obtained in the fasting
state. All lipid and other analyses were conducted on venous blood
samples within 1 week of collection at Bio Medical Laboratories
(BML) (Saitama, Japan). Serum cholesterol and triglyceride levels
were measured by enzymatic assay. High-density-lipoprotein
(HDL) and low-density-lipoprotein cholesterols were measured
enzymatically by a kit from Daiichi Kagaku Co. Ltd. (Tokyo, Japan).
The results of lipid analyses in the four surveys were indirectly
standardized according to the criteria of the Centers for Disease
Control and Prevention (CDC) Lipid Standardization Program.14
Thus, the cholesterol levels in these ﬁve surveys appear to be
comparable. Plasma glucose was determined enzymatically, and
hemoglobin A1c (HbA1c) was determined by a kit from Kyowa
Medex Co. Ltd. (Tokyo, Japan). Serum insulin was determined by
immunoradiometric assay (Abbott Diagnostics Division, Abbot
Park, IL). Waist circumference at the umbilical level was measured
in the late exhalation phase in standing position.
2.3. Deﬁnition of MetS
According to the deﬁnition released by ATP III, published in
2008, we analyzed the prevalence of MetS.Wemodiﬁed the criteria
by using the Asian cutoff of waist circumference (90 cm for men
and 80 cm for women). Other differences are fasting glucose
greater than or equal to 100 mg/dL and HDL cholesterol less than
50 mg/dL in women. MetS of modiﬁed ATP III criteria was deﬁned
as the presence of at least three abnormalities among central
obesity, hypertriglyceridemia, lowHDL cholesterolemia, high blood
pressure, and fasting high glucose. We also analyzed using the
Japanese diagnostic criteria of the MetS in 2005, deﬁning MetS as
the presence of two or more abnormalities in the presence of
central obesity (waist circumference: 85 cm or more in men and
90 cm or more in women). Three abnormalities are as follows: (1)
triglycerides greater than or equal to 150 mg/dL and/or HDL
cholesterol less than 40 mg/dL or under treatment for this type of
dyslipidemia; (2) systolic blood pressure greater than or equal to
130 mmHg and/or diastolic blood pressure greater than or equal to
85 mmHg, or under treatment for high blood pressure; (3) fasting
glucose greater than or equal to 110 mg/dL or under treatment for
diabetes (Table 1). Furthermore, we used modiﬁed IDF criteria for
comparison. People treated with lipid-lowering drugs who had
normal triglyceride and HDL cholesterol in this study were
excluded, because we could not obtain data whether they were
treated for hypercholesterolemia or hypertriglyceridemia.
2.4. Data analysis
The results were expressed as mean value standard devia-
tion. Differences in means were evaluated by unpaired t test,
ManneWhitney test, or analysis of variance, when appropriate.
The categorical variables were compared by chi-square test. The
analysis was performed by the Statistical Package for Social
Sciences (ver. 11.5; SPSS Japan Inc., Tokyo, Japan). A p value of 0.05
or less was considered to indicate a statistically signiﬁcant
difference.
Table 1
Comparison among Japanese, modiﬁed IDF, and modiﬁed ATP III criteria for metabolic syndrome
Deﬁnition of metabolic syndrome Japanese Modiﬁed ATP III for Asians Modiﬁed IDF for Asians
(1)þ any 2 or more of (2)e(4) 3 or more of (1)e(5) (1)þ any 2 or more of (2)e(5)
Components
Central obesity
(waist circumference)
(1) 85 cm (men), 90 cm (women) (1) 90 cm (men), 80 cm (women) (1) 90 cm (men), 80 cm (women)
High blood pressure (2) 130/85 mmHg and/or
antihypertensive medication
(2) 130/85 mmHg and/or
antihypertensive medication
(2) 130/85 mmHg and/or
antihypertensive medication
Fasting high glucose (3) 110 mg/dL and/or
antidiabetic medication
(3) 100 mg/dL and/or
antidiabetic medication
(3) 100 mg/dL and/or
antidiabetic medication
Dyslipidemia (4) Triglyceride 150 mg/dL and/or
HDL-C <40 mg/dL
(4) Triglyceride 150 mg/dL (4) Triglyceride 150 mg/dL
(5) HDL-C <40 mg/dL (men),
<50 mg/dL (women)
(5) HDL-C <40 mg/dL (men),
<50 mg/dL (women)
IDF¼ International Diabetes Federation; ATP III¼Adult Treatment Panel III; HDL-C¼ high-density-lipoprotein cholesterol.
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Table 2 shows the prevalence of MetS in Japanese middle-aged
and elderly men and women according to the Japanese and
modiﬁed ATP III and IDF criteria. According to the Japanese criteria,
the prevalence of MetS was higher in both elderly men and women
(13.3% vs. 18.9% in men and 1.5% vs. 4.8% in women). In women, the
prevalence of MetS was almost three fold higher in the elderly than
that in the middle-aged group (p< 0.01 by chi-square test). When
we apply the modiﬁed ATP III and IDF criteria, the prevalence of
MetS was also increased inwomen of each group (p< 0.01 in ATP III
and IDF criteria by chi-square test), and the three fold increase in
MetS in elderly women was consistent among the three criteria.
The increase of MetS prevalence in women by modiﬁed ATP III and
IDF criteria compared with that by the Japanese criteria was also
statistically signiﬁcant (p< 0.01). Intriguingly, when we used
modiﬁed IDF criteria, the prevalence of MetS in middle-aged and
elderly men was similar to that using the Japanese criteria.
However, the prevalence of MetS inwomen bymodiﬁed IDF criteria
was similar to that by modiﬁed ATP III criteria.
To assess the effect of aging on each metabolic component, we
compared the prevalence of central obesity, dyslipidemia, high
blood pressure, high fasting glucose, and MetS in each age group
according to the Japanese and modiﬁed ATP III criteria. In men, the
prevalence of MetS was similar in each age group; yet, more people
satisﬁed the modiﬁed ATP III criteria than the Japanese criteria
(Table 3). In women, the prevalence of MetS was about 5% in the
elderly, and almost no subjects were diagnosed withMetS less than
65 years old by the Japanese criteria. According to the modiﬁed ATP
III criteria, the prevalence of MetS in women also increased in their
60s andwas almost the same as that of men older than 65 years.We
found a big difference in the prevalence of central obesity diagnosed
by Japanese and Asian criteria for waist circumference in both
genders. Thus, it is critical which cutoff is used to diagnose MetS.
The prevalence of central obesity in men was almost constant
according to the Japanese or Asian criteria of waist circumference,
although the prevalence seemed to be decreased in their 70s.
The prevalence of central obesity in women increased towardTable 2
Prevalence of metabolic syndrome in middle-aged and elderly Japanese
% Male (1425)
40e64 yr (1266) 65e79 y
Japanese criteria 13.3 18.9
Modiﬁed Adult Treatment Panel III 19.0 21.4
Modiﬁed International Diabetes Federation 14.0 14.8
The numbers in parentheses indicate the number of subjects in each group. p Value, 40e
NS¼ not signiﬁcant.menopause and remained almost the same after their 50s.
However, whenwe used the Asian criteria, the prevalence of central
obesity in women further increased in their 70s. The prevalence of
dyslipidemia was almost constant in men among each age group
and increased toward menopause in women. However, the preva-
lence reached a plateau after 55 years of age. As expected, the
prevalence of dyslipidemia was higher in women according to the
ATP III criteria than that by the Japanese criteria. The prevalence of
high blood pressure increased with age both in men and inwomen.
Intriguingly, the prevalence of high blood pressure did not show
further increase after 60 years of age in both genders. The preva-
lence of high fasting glucose increased after 50 years of age in men
and after 65 years of age in women. Thus, the prevalence of MetS
and related components are associated with age, especially with
menopause in women. We also compared the number of the MetS
traits by dividing the cohort into three groups: from 40 to 49 years
(young middle age); from 50 to 64 years (old middle age); and from
65 to 79 years (elderly). As shown in Figure 1, the prevalence of the
subjects with indicated numbers of MetS components according to
themodiﬁed ATP III criteria is quite similar in men of all age groups.
However, in older women, the number of MetS components
increased, which is consistent with the data in Table 2.
Next, we compared the demographic characteristics of men and
women diagnosed with MetS by the modiﬁed ATP III criteria. As
shown in Table 4, age and total, HDL, and low-density-lipoprotein
cholesterol were higher, and waist circumference, triglyceride,
diastolic blood pressure, remnant-like particle (RLP) cholesterol,
and fasting glucose were lower in women than in men.
We then compared the demographic characteristics of elderly
and middle-aged men and women with MetS by modiﬁed ATP III
criteria. As shown in Table 5, systolic blood pressure was higher in
older-middle-aged and elderly than in younger-middle-aged group,
and diastolic blood pressurewas higher in oldermiddle-aged group
in both genders. HDL cholesterol was lower in younger-middle-
aged men and non-HDL cholesterol was lower in elderly men.
Triglyceride was lower in elderly men and women. Insulin levels
decreased according to age in men. There were no statistical
differences in the other components.p Female (941) p
r (159) 40e64 yr (732) 65e79 yr (209)
NS 1.5 4.8 <0.01
NS 9.0 26.8 <0.01
NS 8.2 23.9 <0.01
64 yr vs. 65e79 yr.
Table 3
Prevalence of metabolic syndrome and metabolic components according to the Japanese and modiﬁed ATP III criteria in each age group in the Japanese population (%)
Sex
Criteria and metabolic
components
Male (age group, yr), % Female (age group, yr), %
40e44 45e49 50e54 55e59 60e64 65e69 70e74 75e79 40e44 45e49 50e54 55e59 60e64 65e69 70e74 75e79
n 291 289 359 191 136 67 62 30 171 123 185 108 145 93 75 41
Japanese criteria
Central obesity 49.1 56.4 54.0 57.1 55.1 61.2 48.4 43.3 5.3 11.4 16.8 16.7 11.7 16.1 14.7 17.1
Hypertriglyceridemia 33.7 43.6 31.2 28.8 33.1 25.4 25.8 13.3 6.4 7.3 15.1 22.2 20.7 20.4 18.7 14.6
Low HDL
cholesterolemia
11.3 14.2 12.3 13.1 12.5 9.0 9.7 13.3 1.8 4.1 2.2 2.8 2.8 6.5 2.7 4.9
Dyslipidemia 36.4 46.0 34.5 33.5 36.0 31.3 30.6 20.0 7.6 8.9 15.1 22.2 22.1 21.5 20.0 19.5
High blood pressure 16.2 20.8 28.7 27.2 49.3 41.8 43.5 40.0 8.8 8.9 17.8 19.4 49.7 49.5 40.0 43.9
High fasting glucose 11.3 15.6 19.5 23.6 22.8 22.4 25.8 16.7 1.8 4.9 3.8 10.2 9.7 15.1 16.0 14.6
Metabolic syndrome 9.6 15.2 14.2 12.0 16.2 22.4 17.7 13.3 0.0 0.8 2.2 3.7 1.4 5.4 4.0 4.9
Modiﬁed ATP III criteria
Central obesity 23.7 34.6 30.1 26.7 30.9 38.8 22.6 23.3 18.7 32.5 31.4 47.2 36.6 48.4 60.0 63.4
Hypertriglyceridemia 33.7 43.6 31.2 28.8 33.1 25.4 25.8 13.3 6.4 7.3 15.1 22.2 20.7 20.4 18.7 14.6
Low HDL
cholesterolemia
11.3 14.2 12.3 13.1 12.5 9.0 9.7 13.3 8.2 15.4 15.7 12.0 17.9 23.7 24.0 19.5
Dyslipidemia 36.4 46.0 34.5 33.5 36.0 31.3 30.6 20.0 12.9 17.9 22.7 26.9 29.7 33.3 32.0 31.7
High blood pressure 16.2 20.8 28.7 27.2 49.3 41.8 43.5 40.0 8.8 8.9 17.8 19.4 49.7 49.5 40.0 43.9
High fasting glucose 34.7 38.4 43.2 44.0 39.7 41.8 40.3 36.7 8.8 15.4 14.6 18.5 24.8 29.0 33.3 26.8
Metabolic syndrome 14.1 22.8 19.2 16.2 25.0 22.4 19.4 23.3 1.8 5.7 9.2 13.9 16.6 26.9 30.7 19.5
ATP III¼Adult Treatment Panel III; HDL¼ high-density lipoprotein.
Fig. 1. Prevalence of the subjects with indicated numbers of metabolic syndrome
components according to modiﬁed Adult Treatment Panel III criteria (central obesity,
hypertriglyceridemia, low high-density-lipoprotein cholesterolemia, high blood pres-
sure, high fasting glucose) in each age group of both genders.
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components among the people who satisﬁed the modiﬁed ATP III
criteria according to their age in both genders. As shown in Table 6,
the prevalence of hypertriglyceridemia and dyslipidemia in men
was lower in the elderly, whereas the prevalence of high blood
pressure increased in older-middle-aged and elderly men. In
women, there was a tendency that the prevalence of hyper-
triglyceridemiawas lower in elderly and that of high blood pressure
increased according to age.
4. Discussion
In this study, we compared the prevalence of MetS in the
Japanese middle-aged and elderly population by the Japanese andTable 4
Demographic characteristics of men and women with metabolic syndrome
Male (n¼ 467) Female (n¼ 201) p
Mean SD Mean SD
Age, yr 53.4 8.8 61.9 9.4 <0.01
Body mass index 25.9 3.0 26.3 2.9 0.27
Waist circumference, cm 92.1 6.7 86.2 8.0 <0.01
Systolic blood pressure,
mmHg
136 18 135 18 0.69
Diastolic blood pressure,
mmHg
84 12.6 81 9.9 0.02
T-Cho, mg/dL 214 35.4 224 33.6 0.01
TG, mg/dL 197 155, 268 159 115, 194 <0.01
HDL-C, mg/dL 45.7 12.2 51.7 11.0 <0.01
Low-density-lipoprotein
cholesterol, mg/dL
126 34.0 140 30.0 <0.01
Non-HDL-C, mg/dL 168 35.8 173 32.5 0.24
RLP-C, mg/dL 6.6 4.2, 10.7 4.3 3.2, 8.5 0.02
HbA1c, % 5.3 0.77 5.4 0.82 0.15
FBS, mg/dL 108 26 100 18.4 0.01
Insulin, mU/mL 8.3 4.7 8.0 4.4 0.52
TG and RLP-C are expressed as median (interquartile range). The difference was
analyzed by unpaired t test except for TG and RLP-C. ManneWhitney test was used
for TG and RLP-C.
SD¼ standard deviation; HDL-C¼ high-density-lipoprotein cholesterol; T-cho ¼
total cholesterol; TG ¼ triglyceride; RLP-C ¼ remnant-like particle cholesterol;
HbA1c¼ hemoglobin A1c; FBS ¼ fasting blood sugar.
Table 5
Demographic data of subjects with metabolic syndrome in each age group
Sex 40e49 yr
(M, 195; F, 27)
50e64 yr
(M, 223; F, 102)
65e79 yr
(M, 49; F, 72)
p
Mean SD Mean SD Mean SD
Body mass index M 26.1 3.0 25.9 3.1 25.5 2.5 0.55
F 26.7 2.1 26.3 3.1 26.1 2.7 0.78
Waist circumference, cm M 92.2 7.0 91.9 6.8 92.2 5.8 0.96
F 87.9 8.7 85.6 9.1 86.3 6.7 0.65
Systolic blood pressure, mmHg M 130 17.6 138 18.1 143 17.7 <0.01
F 125 18.0 140 19.4 132 14.6 0.01
Diastolic blood pressure, mmHg M 82 13.1 86 12.5 82 9.4 0.02
F 80 11.2 84 10.9 79 7.8 0.04
T-Cho, mg/dL M 219 34.9 212 35.6 203 33.6 0.06
F 213 28.8 230 33.2 220 34.3 0.13
TG, mg/dL M 272 154 234 242 171 71 0.03
F 169 79.7 189 89.6 144 57.1 0.01
HDL-C, mg/dL M 43.1 8.3 47.2 13.7 47.9 14.9 0.02
F 48.3 9.6 52.9 11.5 51.4 10.7 0.38
Low-density-lipoprotein cholesterol, mg/dL M 128 34.8 126 34.2 121 31.6 0.62
F 131 26.2 142 28.9 140 31.1 0.51
Non-HDL-C, mg/dL M 176 34.8 165 36.4 155 32.3 0.01
F 165 33.5 178 31.0 169 33.6 0.26
HbA1c, % M 5.1 0.7 5.4 0.9 5.4 0.6 0.14
F 5.3 0.7 5.3 1.0 5.5 0.7 0.63
FBS, mg/dL M 112 24.3 113 25.2 108 21.5 0.58
F 100 13.6 106 22.5 106 19.7 0.61
Insulin, mU/mL M 9.4 5.9 7.8 3.8 7.2 3.4 0.01
F 7.9 2.0 8.1 3.6 8.0 5.6 0.98
p Value was analyzed by analysis of variance.
M¼male; F¼ female; HDL-C¼ high-density-lipoprotein cholesterol; T-cho ¼ total cholesterol; TG ¼ triglyceride; RLP-C ¼ remnant-like particle cholesterol; HbA1c¼
hemoglobin A1c; FBS ¼ fasting blood sugar.
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MetS was almost three fold higher by all the three criteria in elderly
women than in middle-aged women, whereas there was almost no
difference between middle-aged and elderly men. Consistent with
ourﬁndings that the prevalence ofMetS increased in elderlywomen
compared with that in middle-aged population, other studies have
also shown that the prevalence of MetS increases with increasing
age.15 Ford et al.15 reported that the prevalence of MetS in subjects
older than 60 years is approximately 40% in the Third Report of the
National Cholesterol Education ProgramExpert Panel, inwhich they
used the cutoff of 110 mg/dL for high fasting glucose and their
criteria of waist circumference for central obesity. The prevalence of
MetS in middle-aged population is approximately 25% in both
genders, which is different from the result in our cohort. In Japan,
Ishizaka et al.16 andAizawa et al.17 have shown that the prevalence of
MetS in men is approximately 20% in both middle-aged and elderly
populations, whereas that inwomen is approximately 5% and 10% inTable 6
Prevalence of each metabolic abnormality in each age group in the subjects with
metabolic syndrome
Sex Age group (yr) p
40e49 50e64 65e79
Central obesity M 74.5 72.1 82.4 0.47
F 92.3 82.8 89.3 0.48
Hypertriglyceridemia M 92.5 72.9 58.8 <0.01
F 61.5 69 48.2 0.08
Low HDL cholesterolemia M 39.6 34.3 32.4 0.61
F 69.2 46.6 55.4 0.29
Dyslipidemia M 94.3 77.9 73.5 <0.01
F 76.9 79.3 71.4 0.62
High blood pressure M 50.9 70.0 85.3 <0.01
F 46.2 67.2 76.8 0.09
High fasting glucose M 79.3 82.1 79.4 0.75
F 46.2 65.5 64.3 0.41
The difference was analyzed by chi-square test.
M¼male; F¼ female.middle-aged and elderly populations, respectively, although they
used the original ATP III criteria and BMI instead of waist circum-
ference. Tanaka et al.18 also showed that the prevalence of MetS in
Okinawa, a group of islands located in southwest of Japan, is
approximately30% inmiddle-agedandelderlymenand10%and20%
inmiddle-aged and elderlywomen, respectively, when theyuseATP
III criteriawith the Japanese cutoff of waist circumference. Thus, the
higher prevalence ofMetS inmiddle-aged and elderlymen than that
inwomen is consistent in Japanese cohorts, although the prevalence
is different with each diagnostic criterion.
Among the metabolic components, the prevalence of central
obesity and dyslipidemia increased with aging only in women, and
that of high fasting glucose and high blood pressure increased in both
genders (Table3). Theprevalenceofdyslipidemiadecreased inelderly
men. Thus, middle-agedmen tend to bemore dyslipidemic, whereas
elderly population tends to have a higher prevalence of central
obesity, impaired glucose metabolism, and high blood pressure.
Among the subjects diagnosedwithMetS bymodiﬁed ATP III criteria,
systolicbloodpressure increasedwithaging inbothgenders,whereas
triglyceride and insulin decreased with aging in both genders, and
insulin levels decreased with aging only in men (Table 5). The
increasedprevalenceofhighbloodpressure inoldermiddle-agedand
elderly population is also conﬁrmed in Table 6, although the p value
wasnot statistically signiﬁcant inwomen.Thus, bloodpressure seems
to have the strongest association with aging in both genders. The
prevalenceof central obesitydidnot increasewithaging in the female
subjectswithMetS (Tables5 and6),whereas theprevalenceof central
obesity increased in female general population, as shown in Table 3.
Thus, central obesity inwomenseems tobeaffectedbyaging,which is
consistent with the results of other studies in Japan.16,18 In men, the
insulin levels decreased in the elderly in spite of the fact that FBS and
HbA1c were not changed among the three groups, suggesting
impaired insulin secretion in elderly menwith MetS.
In this study, we used the Japanese and modiﬁed ATP III and IDF
deﬁnitions to determineMetS. However, therewas a large difference
in theprevalenceofMetS amongthethreedeﬁnitions. Thisdifference
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obesity for its diagnosis as in the modiﬁed IDF criteria and has more
stringent criteria for high fasting glucose for both genders and for
HDL cholesterol forwomen.As shown in this study, theprevalenceof
MetS in elderly women by the Japanese criteria was very low. This is
the reason why we used various analyses using modiﬁed ATP III
criteria in this cohort. However, the Japanese guideline forMetS was
established to identify patients with central obesity, who can reduce
the risks by weight loss, whereas the ATP III criteria try to identify
patients with multiple risk factors. Therefore, the Japanese criteria
should be used to identify obese patients who can have a beneﬁt by
weight loss in middle-aged and elderly populations. However, in
terms of risk prediction, there have been several reports discussing
the cutoff levels of MetS components. Hata et al.13 have shown
signiﬁcant associationsbetweenMetSdeﬁnedbyvarious criteria and
the risk of ischemic stroke in the Hisayama study. In the study, they
found that MetS was an independent risk factor for ischemic stroke
when they used themodiﬁed Japanese criteria with Asian deﬁnition
of central obesity. Another study from the same group showed that
the optimal cutoff level of waist circumference to predict cardiovas-
cular diseasewas 90 cm inmen and80 cm inwomen,19 asweused in
modiﬁedATP III deﬁnition in this study. Sone et al.11 also proposed to
use the Asian cutoff for waist circumference to deﬁne central obesity
from the data of Japan Diabetes Complication Study. In terms of the
appropriate cutoff level of HDL cholesterol for the deﬁnition of MetS
in Japanese women, not so many analyses have been done. In our
study, the prevalence of low HDL cholesterolemia with the cutoff of
40 mg/dL was less than 5% and was approximately 20% with the
cutoff of 50 mg/dL in elderly women. We previously showed that
central obesity was signiﬁcantly associated with low HDL choles-
terolemia only when we used the cutoff of 50 mg/dL for women.5
Therefore, further study is necessary to determine the appropriate
cutoff level of HDL cholesterol in women.
In summary, we have shown the prevalence of MetS in Japanese
elderly and middle-aged population using Japanese and modiﬁed
ATP III and IDF criteria, and found the effect of aging on the prev-
alence only in women with either criterion. We also showed the
effect of aging on each metabolic component in this cohort. Thus,
aging is an important factor that affects the metabolic abnormality,
and aging of the population would lead to the increase in the
prevalence of MetS. Therefore, the development of better
approaches to the prevention and management of MetS is neces-
sary for successful aging in our society.
Acknowledgments
This study was supported by research grants for health sciences
from the Japanese Ministry of Health, Labour and Welfare and by
Osaka Pharmaceutical Manufacturers Association. The authors also
thank Dr Hiroshi Kanamori (Hyogo Prefectural Amagasaki Hospital)
for his help in the statistical analysis.References
1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al.
Harmonizing the metabolic syndrome: a joint interim statement of the Inter-
national Diabetes Federation Task Force on Epidemiology and Prevention;
National Heart, Lung, and Blood Institute; American Heart Association; World
Heart Federation; International Atherosclerosis Society; and International
Association for the Study of Obesity. Circulation 2009;120:1640e5.
2. Facchini FS, Hua N, Abbasi F, Reaven GM. Insulin resistance as a predictor of
age-related diseases. J Clin Endocrinol Metab 2001;86:3574e8.
3. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet
2005;365:1415e28.
4. Yaffe K. Metabolic syndrome and cognitive disorders: is the sum greater than
its parts? Alzheimer Dis Assoc Disord 2007;21:167e71.
5. Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, et al. Prev-
alence of metabolic syndrome in the general Japanese population in 2000.
J Atheroscler Thromb 2006;13:202e8.
6. Yamamoto A, Horibe H, Mabuchi H, Kita T, Matsuzawa Y, Saito Y, et al.
Analysis of serum lipid levels in Japanese men and women according to body
mass index. Increase in risk of atherosclerosis in postmenopausal women.
Research Group on Serum Lipid Survey 1990 in Japan. Atherosclerosis 1999;
143:55e73.
7. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic
syndrome: a global public health problem and a new deﬁnition. J Atheroscler
Thromb 2005;12:295e300.
8. Matsuzawa Y. Metabolic syndromeddeﬁnition and diagnostic criteria in Japan.
J Atheroscler Thromb 2005;12:301.
9. Oka R, Kobayashi J, Yagi K, Tanii H, Miyamoto S, Asano A, et al. Reassessment of
the cutoff values of waist circumference and visceral fat area for identifying
Japanese subjects at risk for the metabolic syndrome. Diabetes Res Clin Pract
2008;79:474e81.
10. Sato A, Asayama K, Ohkubo T, Kikuya M, Obara T, Metoki H, et al. Optimal
cutoff point of waist circumference and use of home blood pressure as
a deﬁnition of metabolic syndrome: the Ohasama study. Am J Hypertens
2008;21:514e20.
11. Sone H, Tanaka S, Iimuro S, Oida K, Yamasaki Y, Oikawa S, et al. Components of
metabolic syndrome and their combinations as predictors of cardiovascular
disease in Japanese patients with type 2 diabetes. Implications for improved
deﬁnition. Analysis from Japan Diabetes Complications Study (JDCS).
J Atheroscler Thromb 2009;16:380e7.
12. Kashihara H, Lee JS, Kawakubo K, Tamura M, Akabayashi A. Criteria of
waist circumference according to computed tomographydmeasured visceral
fat area and the clustering of cardiovascular risk factors. Circ J 2009;73:1881e6.
13. Hata J, Doi Y, Ninomiya T, Tanizaki Y, Yonemoto K, Fukuhara M, et al. The effect
of metabolic syndrome deﬁned by various criteria on the development of
ischemic stroke subtypes in a general Japanese population. Atherosclerosis
2009;210:249e55.
14. Johnson CL, Rifkind BM, Sempos CT, Carroll MD, Bachorik PS, Briefel RR, et al.
Declining serum total cholesterol levels among US adults. The National Health
and Nutrition Examination Surveys. JAMA 1993;269:3002e8.
15. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US
adults: ﬁndings from the third National Health and Nutrition Examination
Survey. JAMA 2002;287:356e9.
16. Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M. Hyper-
tension is the most common component of metabolic syndrome and the
greatest contributor to carotid arteriosclerosis in apparently healthy Japanese
individuals. Hypertens Res 2005;28:27e34.
17. Aizawa Y, Kamimura N, Watanabe H, Makiyama Y, Usuda Y, Watanabe T, et al.
Cardiovascular risk factors are really linked in the metabolic syndrome: this
phenomenon suggests clustering rather than coincidence. Int J Cardiol
2006;109:213e8.
18. Tanaka H, Shimabukuro T, Shimabukuro M. High prevalence of metabolic
syndrome among men in Okinawa. J Atheroscler Thromb 2005;12(5):284e8.
19. Doi Y, Ninomiya T, Hata J, Yonemoto K, Arima H, Kubo M, et al. Proposed
criteria for metabolic syndrome in Japanese based on prospective evidence: the
Hisayama study. Stroke 2009;40:1187e94.
